Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2016 1
2017 3
2018 1
2019 1
2023 4
2024 8
2025 10
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.
Arnon J, Dinstag G, Tirosh O, Gugel L, Kinar Y, Gottlieb T, Elia A, Rottenberg Y, Nechushtan H, Tabi M, Blumenfeld P, Pikarsky E, Beker T, Aharonov R, Popovtzer A. Arnon J, et al. Among authors: blumenfeld p. J Immunother Cancer. 2025 Jan 11;13(1):e010132. doi: 10.1136/jitc-2024-010132. J Immunother Cancer. 2025. PMID: 39800380 Free PMC article.
Commissioning of a novel gantry-less proton therapy system.
Feldman J, Pryanichnikov A, Achkienasi A, Polyansky I, Hillman Y, Raskin S, Blumenfeld P, Popovtzer A, Marash M. Feldman J, et al. Among authors: blumenfeld p. Front Oncol. 2024 Nov 7;14:1417393. doi: 10.3389/fonc.2024.1417393. eCollection 2024. Front Oncol. 2024. PMID: 39575421 Free PMC article.
Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study.
Iluz A, Maoz M, Lavi N, Charbit H, Or O, Olshinka N, Demma JA, Adileh M, Wygoda M, Blumenfeld P, Gliner-Ron M, Azraq Y, Moss J, Peretz T, Eden A, Zick A, Lavon I. Iluz A, et al. Among authors: blumenfeld p. Cancers (Basel). 2023 Aug 18;15(16):4168. doi: 10.3390/cancers15164168. Cancers (Basel). 2023. PMID: 37627196 Free PMC article.
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study.
Peled N, Roisman LC, Levison E, Dudnik J, Chernomordikov E, Heching N, Dudnik E, Keren-Rosenberg S, Nechushtan H, Salhab A, Hershkovitz D, Tsuriel S, Hannes V, Rotem O, Lazarev I, Lichtenberg R, Granot IS, Krayim B, Shalata W, Levin D, Krutman Y, Allen AM, Blumenfeld P, Lavrenkov K, Kian W. Peled N, et al. Among authors: blumenfeld p. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):105-114. doi: 10.1016/j.ijrobp.2023.03.042. Epub 2023 Mar 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 36925073 Clinical Trial.
30 results